upon a single source . relevant discussion may be found on the talk page . please help improve this article by introducing citations to additional sources . april 2014 csl behring llc headquarters king of prussia pennsylvania key people paul perreault ceo and managing director of csl limited number of employees 14 000 1 website http www.cslbehring.com csl behring is a biopharmaceutical company manufacturing plasma derived and recombinant therapeutic products . its line of therapies includes products for the treatment of bleeding disorders such as hemophilia and von willebrand disease ; primary immune deficiencies pidd ; hereditary angioedema ; inherited respiratory disease ; and neurological disorders in certain markets . the company s products are also used in cardiac surgery organ transplantation burn treatment and to prevent hemolytic diseases in the newborn . 2 csl behring operates the plasma collection network csl plasma . 3 contents 1 company statistics 2 history 3 products 4 offices 5 external links 6 references company statistics edit parent company csl limited asx csl melbourne australia headquarters king of prussia pa employees 14 000 4 operations in 30 countries ceo and managing director paul perreault 5 r & d marburg germany ; bern switzerland ; king of prussia pennsylvania usa ; tokyo japan ; broadmeadows and parkville victoria australia . history edit csl behring is a member of the csl group of companies . parent company csl limited asx csl is a specialty biopharmaceutical company headquartered in parkville australia . as part of a global alignment the csl behring brand was established in 2007 . previously known as zlb behring the company s history dates back to 1904 . 6 csl behring traces its heritage back to emil von behring the inventor of serum therapy or serology . year event 7 1901 emil von behring received the nobel prize in physiology or medicine . 8 1904 emil von behring founded the behringwerke in marburg germany for the purpose of experimental work on disease prevention and for the manufacture of sera and vaccines . 1913 behringwerke expands to produce a gas gangrene antiserum and a cholera vaccine . 1916 csl then commonwealth serum laboratories was established in australia with the goal of providing vaccines to the people of australia and new zealand . 1917 csl produced 3 million doses of a mixed bacterial vaccine to combat the 1919 influenza pandemic . 1930 csl released its antivenom for tiger snake bites . 1940 armour pharmaceuticals a predecessor company in kankakee illinois became a supplier of human albumin the most abundant protein in human blood plasma in world war ii . 1944 csl began producing penicillin for the military and australia to supply the drug to civilians at no charge . 1949 zlb zentrallaboratorium blutspendedienst a predecessor company is established in bern switzerland as a department of the swiss red cross and holds its first donor blood sessions in switzerland . 1954 australian csl officer val bazeley assists jonas salk with the production of the experimental polio vaccine used in the first clinical trials in the us . bazeley returns to australia to set up production of the salk vaccine at csl . 1966 rh d immunoglobulin produced from plasma is introduced by csl for haemolytic disease in newborns . 1981 behringwerke introduces haemate human plasma coagulation factor viii von willebrand factor complex for the treatment of patients with hemophilia a. 1991 csl limited is incorporated in australia . 2000 zlb bioplasma a predecessor company is established acquiring the plasma fractionation assets from srk a nonprofit organization affiliated with the swiss red cross . 2001 aventis behring a predecessor company acquires 42 plasma centers . 2004 csl limited completes the acquisition of aventis behring combining it with zlb bioplasma to create zlb behring later csl behring . 2007 zlb behring becomes csl behring . 2009 zlb plasma changes its name to csl plasma to align with its parent company csl behring and opens the plasma testing laboratories in knoxville tennessee . 2009 national organization for rare disorders nord recognized csl behring for developing and marketing a treatment in the u.s. for acute bleeding episodes in patients with congenital fibrinogen deficiency an extremely rare potentially life threatening bleeding disorder . 2009 csl behring awarded the swiss government s tell award for innovations in manufacturing and protein therapies . 2012 european organisation for rare disorders recognized csl behring for its work developing and manufacturing therapies used to treat rare and serious medical conditions with the 2012 eurordis award . products edit csl behring researches develops manufactures and markets a range of plasma derived and recombinant products and related services specializing in the treatment of rare and serious diseases . its line of therapies includes products for the treatment of bleeding disorders such as hemophilia and von willebrand disease ; primary immune deficiencies ; hereditary angioedema ; inherited respiratory disease ; and neurological disorders in certain markets . the company s products are also used in cardiac surgery organ transplantation burn treatment and to prevent hemolytic diseases in the newborn . 1 immunology beriglobin p human hepatitis a immunoglobulin liquid 16 % solution for intramuscular injection berirab p human rabies immunoglobulin liquid 16 % solution for intramuscular injection carimune nf sandoglobulin sanglopor human normal immunoglobulin freeze dried formulations for intravenous administration cytogam human cytomegalovirus immunoglobulin . liquid immunoglobulin containing a standardized amount of antibody to cytomegalovirus . hepatitis b immunoglobulin p behring human hepatitis b immunoglobulin liquid 16 % solution for intramuscular injection hizentra human normal immunoglobulin . liquid 20 % immunoglobulin solution ready to use for subcutaneous administration privigen human polyvalent immunoglobulin liquid 10 % solution for intravenous injection rhophylac human anti d immunoglobulin . prefilled syringes of highly purified anti rhesus factor d igg for intravenous administration and intramuscular injection . tetagam p human tetanus immunoglobulin liquid 16 % solution for intramuscular injection varicellon p human varicella immunoglobulin liquid 16 % solution for intramuscular injection coagulation bleeding disorders beriate freeze dried human coagulation factor viii concentrate berinin p freeze dried human coagulation factor ix concentrate beriplex p n kcentra a non activated 4 factor prothrombin complex concentrate 4f pcc for urgent warfarin reversal factor x p behring a freeze dried human coagulation factor ix and factor x concentrate fibrogammin p and corifact freeze dried human coagulation factor xiii concentrate helixate fs and helixate nexgen freeze dried recombinant coagulation factor viii humate p and haemate p freeze dried human coagulation factor viii c and von willebrand factor concentrate idelvion freeze dried recombinant coagulation factor ix albumin fusion protein monoclate p a freeze dried monoclonal antibody purified human coagulation factor viii concentrate mononine a freeze dried human coagulation factor ix that has been purified using monoclonal antibodies octostim a synthetic desmopressin acetate nasal spray riastap human coagulation factor i freeze dried factor i concentrate stimate a synthetic desmopressin acetate nasal spray pulmonary zemaira freeze dried human alpha1 proteinase inhibitor a1 pi critical care alburx alburex human albumin behring albuminar human albumin solution 5 % 20 % or 25 % human albumin solutions berinert p freeze dried human c1 esterase inhibitor c1 inh concentrate beriplex p n kcentra freeze dried human prothrombin complex concentrate haemocomplettan p riastap freeze dried human fibrinogen factor i concentrate kybernin p freeze dried human antithrombin iii concentrate streptase freeze dried streptokinase wound healing beriplast p combi set fibrin sealant kit freeze dried fibrin sealant for topical application fibrogammin p freeze dried human coagulation factor xiii concentrate tachocomb fibrin sealant fleece type fleece type collagen preparations coated with fibrin glue components note product availability varies from country to country depending on registration status . 9 offices edit the company is headquartered in king of prussia pennsylvania . 10 it has 14 000 employees in 30 countries . 11 major manufacturing centers are located in bern switzerland marburg germany kankakee illinois and broadmeadows australia . 12 external links edit official website parent company csl limited csl plasma customer service biography of emil von behring references edit http cslbehring.com about http cslbehring.com about http cslplasma.com about.htm http cslbehring.com about http cslbehring.com about management team.htm http cslbehring.com about heritage history.htm http cslbehring.com about heritage history.htm http nobelprize.org nobel prizes medicine laureates 1901 behring bio.html http cslbehring.com docs 555 221 global % 20product % 20portfolio 03.11.10.pdf http cslbehring.com about worldwide locations.htm http cslbehring.com about http cslbehring.com about worldwide locations.htm manufacturing retrieved from https en.wikipedia.org w index.php title csl behring & oldid 743226306 categories companies based in montgomery county pennsylvaniabiopharmaceutical companieshidden categories articles needing additional references from april 2014all articles needing additional referencespages using infobox company with unsupported parameterscompanies with year of establishment missing navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages catal deutsch edit links this page was last modified on 8 october 2016 at 16 33 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view